Clinical Trial Update: Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hormone therapy with or without docetaxel in metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Hormone therapy

Snippet

Sponsor: UNICANCER | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED